Dimensional Fund Advisors
TPST icon

Dimensional Fund Advisors’s Tempest Therapeutics TPST Stock Holding History

Dimensional Fund Advisors’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8K Hold
11,444
– – ﹤0.01% 3207
2025
Q4 		$32.8K Buy
+11,444
New +$81K ﹤0.01% 3225
2024
Q3 		– Sell
-1,930
Closed -$54.9K – 3390
2024
Q2 		$54.9K Buy
+1,930
New +$83.5K ﹤0.01% 3303
2021
Q2 		– Sell
-263
Closed -$61K – 3477
2021
Q1 		$61K Buy
263
+190
+260% +$76.8K ﹤0.01% 3383
2020
Q4 		$31K Buy
73
+20
+38% +$6.91K ﹤0.01% 3336
2020
Q3 		$17K Sell
53
-185
-78% -$62.7K ﹤0.01% 3329
2020
Q2 		$82K Sell
238
-9
-4% -$3.59K ﹤0.01% 3289
2020
Q1 		$254K Buy
247
+92
+59% +$134K ﹤0.01% 3174
2019
Q4 		$204K Buy
155
+8
+5% +$11.3K ﹤0.01% 3260
2019
Q3 		$204K Buy
147
+23
+19% +$37.1K ﹤0.01% 3280
2019
Q2 		$280K Buy
+124
New +$365K ﹤0.01% 3278
2017
Q4 		– Sell
-4
Closed -$16K – 3341
2017
Q3 		$16K Sell
4
-2
-33% -$8.55K ﹤0.01% 3330
2017
Q2 		$28K Hold
6
– – ﹤0.01% 3299
2017
Q1 		$33K Sell
6
-1
-14% -$4.66K ﹤0.01% 3288
2016
Q4 		$33K Hold
7
– – ﹤0.01% 3279
2016
Q3 		$154K Buy
7
+2
+40% +$36.2K ﹤0.01% 3201
2016
Q2 		$70K Buy
+5
New +$114K ﹤0.01% 3251

Other funds holding TPST

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Dimensional Fund Advisors's TPST Position: Q1 2026 in Review

Dimensional Fund Advisors held its Tempest Therapeutics (TPST) position steady in Q1 2026 at 11,444 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Dimensional Fund Advisors first reported a position in TPST in Q2 2016 and has held it in 17 quarters since. The position peaked at $280K in Q2 2019. 22 funds tracked by Wall St. Rank hold TPST as of Q1 2026.

  • Dimensional Fund Advisors held 11,444 shares of Tempest Therapeutics worth $18.8K as of Q1 2026.
  • Dimensional Fund Advisors left its Tempest Therapeutics share count unchanged in Q1 2026.
  • Tempest Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #3207 holding.
  • Dimensional Fund Advisors first reported a position in Tempest Therapeutics in Q2 2016 and has held it in 17 quarters since.
  • Dimensional Fund Advisors's Tempest Therapeutics position peaked at $280K in Q2 2019.
  • 22 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.